The in vitro Effect of Doxorubicine-G2-FA Treatment on Breast Cancer Copyright
2020
BACKGROUND:
To achieve delivery of a drug to tumors, folic acid (FA) was used as a targeting ligand to
change nanocarriers. Since the folate receptor has more expression in several tumor types such as breast cancer.
OBJECTIVES:
The present study aimed to evaluate the effect of Doxorubicine-G2-FA (Dox- G2-FA) with
in vitro assays. The abbreviation of G2 represents the second generation of dendrimer synthesis.
METHODS:
For this purpose, Dox-G2-FA was synthesized and mass spectroscopy was used to confirm the
synthesized component. Also, MTT assay, flow cytometry, and gene expression assay by real-time PCR were
used to evaluate cell viability, apoptosis, and necrosis.
RESULTS:
In this study, the effect of Dox and Dox-G2-FA on the expression of Bax, Bcl2 genes showed
that there was a significant decrease in the expression of the Bcl2 gene in the Dox-G2-FA group compared to
Dox and control groups(
P<0.05). Also, the results of flow-cytometry showed that apoptosis in the presence of
Dox-G2-FA was greater than in the Dox group (
P<0.05).
CONCLUSIONS:
Therefore, it seems that the effect of Dox-G2-FA on apoptosis is better than the effect of
Dox usage alone.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI